切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2018, Vol. 12 ›› Issue (08) : 445 -450. doi: 10.3877/cma.j.issn.1674-0785.2018.08.004

所属专题: 文献

临床研究

中文版8条目Morisky服药依从性量表在2型糖尿病患者中的信效度评价及应用研究
翁艳君1, 赵豫梅1, 刘伟军1, 宋滇平1,()   
  1. 1. 650032 昆明医科大学第一附属医院糖尿病科
  • 收稿日期:2018-01-03 出版日期:2018-04-15
  • 通信作者: 宋滇平

Reliability and validity of Chinese version of 8-item Morisky medication adherence scale in patients with type 2 diabetes

Yanjun Weng1, Yumei Zhao1, Weijun Liu1, Dianping Song1,()   

  1. 1. Department of Diabetes, the First Affiliated Hospital of Kunming Medical University, Kunming 650032, China
  • Received:2018-01-03 Published:2018-04-15
  • Corresponding author: Dianping Song
  • About author:
    Corresponding author: Song Dianping, Email:
引用本文:

翁艳君, 赵豫梅, 刘伟军, 宋滇平. 中文版8条目Morisky服药依从性量表在2型糖尿病患者中的信效度评价及应用研究[J/OL]. 中华临床医师杂志(电子版), 2018, 12(08): 445-450.

Yanjun Weng, Yumei Zhao, Weijun Liu, Dianping Song. Reliability and validity of Chinese version of 8-item Morisky medication adherence scale in patients with type 2 diabetes[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2018, 12(08): 445-450.

目的

评价中文版8条目Morisky服药依从性量表(MMAS-8)在2型糖尿病患者中应用的信度、效度,探讨不同因素对患者服药依从性的影响。

方法

选取2014年7月至2015年1月就诊于昆明医科大学第一附属医院的148例2型糖尿病患者,进行中文版MMAS-8及4条目Morisky服药依从性量表(MMAS-4)的调查。对中文版MMAS-8,选用Cronbach′s α系数评价其内部一致性信度,选用组内相关系数(ICC)评价重测信度;采用主成分因子分析法评价结构效度,采用Spearman相关系数评价聚合效度。对血糖达标组与血糖未达标组中文版MMAS-8得分采用两独立样本t检验进行比较,对血糖达标组与血糖未达标组服药依从性分布采用χ2检验进行比较,评价中文版MMAS-8区分效度。对2型糖尿病患者服药依从性影响因素采用多因素有序多分类logistic回归方法进行分析。

结果

中文版MMAS-8的Cronbach′s α系数为0.776,ICC为0.854(P<0.05);主成分因子分析法共提取3个公因子;MMAS-8与MMAS-4评分的相关系数为0.878(P<0.001);血糖达标组(糖化血红蛋白<7%)MMAS-8得分高于血糖未达标组(糖化血红蛋白≥7%),差异具有统计学意义[(7.20±1.04)vs(5.94±2.03),t=3.910,P<0.001],两组间低、中等、高依从性分布比较,差异有统计学意义(χ2=14.554,P=0.010)。影响2型糖尿病患者服药依从性的多因素有序多分类logistic回归分析提示:男性患者较女性患者服药依从性低(OR=0.405,95%CI=0.197~0.829,P=0.013);职工医保患者较自费患者服药依从性低(OR=0.130,95%CI=0.021~0.800,P=0.028);单药治疗较联合治疗患者依从性高(OR=2.970,95%CI=1.499~5.882,P=0.002)。年龄、病程、学历、职业、BMI、并发症、合并症、胰岛素治疗与否对服药依从性无显著影响,差异无统计学意义(P均>0.05)。

结论

中文版MMAS-8具有良好的信度、效度;2型糖尿病患者的服药依从性与性别、医保类型及降糖方案有关。

Objective

To evaluate the reliability and validity of the Chinese version of the 8-item Morisky medication adherence scale (MMAS-8) in patients with type 2 diabetes and to explore the influence of different factors on patient medication compliance.

Methods

We used the Chinese version of MMAS-8 and MMAS-4 to survey 148 type 2 diabetes patients who were treated at the First Affiliated Hospital of Kunming Medical University from July 2014 to January 2015. For the Chinese version of MMAS-8, we used Cronbach′s alpha to evaluate its internal consistency reliability, and intra-group correlation coefficient (ICC) to evaluate the test-retest reliability; we also used principal component factor analysis to evaluate construct validity and Spearman correlation coefficient to evaluate the convergent validity.Two independent sample t-tests were used to compare the scores of the Chinese version of MMAS-8 in patients with good glycemic control and those with poor glycemic control, and the chi-square test was used to compare the distribution of drug adherence in patients with good glycemic control and those with poor glycemic control, in order to evaluate discriminant validity of the Chinese version of MMAS-8. Multivariate logistic regression analysis was used to analyze the influencing factors of drug adherence in type 2 diabetes patients.

Results

The Cronbach′s alpha of the Chinese version of the MMAS-8 was 0.776, and the ICC was 0.854 (P<0.05). Principal component factor analysis extracted three common factors. The correlation coefficient between the MMAS-8 and MMAS-4 was 0.878 (P<0.001). The MMAS-8 score was significantly higher in patients with good glycemic control (HbA1c<7%) than in those with poor glycemic control (HbA1c≥7%) [(7.20±1.04) vs (5.94±2.03), t=3.910, P<0.001], and the distribution of patients with different compliance also differed significantly between the two groups (χ2=14.554, P=0.010). Multivariate logistic regression analysis showed that men compared to women (OR=0.405, 95%CI=0.197-0.829, P=0.013), medical insurance for urban workers compared to self-paying (OR=0.130, 95%CI=0.021-0.800, P=0.028), and monotherapy compared to multi-drug treatment (OR=2.970, 95%CI=1.499-5.882, P=0.002) had a significant effect on medication adherence. Age, course of disease, education, occupation, body mass index, complications, and insulin treatment had no significant effect on medication compliance (P>0.05).

Conclusion

The Chinese version of the MMAS-8 has good reliability and validity. The medication adherence of patients with type 2 diabetes is associated with gender, the type of medical insurance, and hypoglycemic therapy.

表1 148例2型糖尿病患者中文版MMAS-8得分分布情况
表2 中文版MMAS-8的结构效度
表3 血糖达标组与血糖未达标组患者服药依从性分布比较(例)
表4 服药依从性影响因素有序多分类logistic回归分析的变量赋值
表5 服药依从性影响因素的有序多分类logistic回归分析
1
Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults [J]. JAMA, 2013, 310(9):948-959.
2
Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes [J]. Clin Ther, 2011, 33(1):74-109.
3
Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting [J]. J Clin Hypertens(Greenwich), 2008, 10(5):348-354.
4
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation [J]. Diabet Med, 1998, 15(7):539-553.
5
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence [J]. Med Care, 1986, 24(1):67-74.
6
戴俊明,傅华,沈贻谔. 原发性高血压药物治疗依从性研究 [J]. 中国慢性病预防与控制, 2000, 8(3):143-145.
7
李灿,辛玲. 调查问卷的信度与效度的评价方法研究 [J]. 中国卫生统计, 2008, 25(5):541-544.
8
马文军,潘波. 问卷的信度和效度以及如何用SAS软件分析 [J]. 中国卫生统计, 2000, 17(6):364-365.
9
刘朝杰. 问卷的信度与效度评价 [J]. 中国慢性病预防与控制, 1997(4):32-35.
10
Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes [J]. Ann Pharmacother, 2009, 43(5):950-957.
11
Feldman BS, Cohen-Stavi CJ, Leibowitz M, et al. Defining the role of medication adherence in poor glycemic control among a general adult population with diabetes [J]. PLoS One, 2014, 9(9):e108145.
12
刘军祥,叶运莉,李爱玲. 糖尿病病人药物治疗依从性影响因素调查 [J]. 现代预防医学, 2007, 34(14):2670-2671.
13
Cheong C, Barner JC, Lawson KA, et al. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients [J]. Clin Ther, 2008, 30(10):1893-1907.
14
Gibson TB, Song X, Alemayehu B, et al. Cost sharing, adherence, and health outcomes in patients with diabetes [J]. Am J Manag Care, 2010, 16(8):589-600.
15
Chang A, Liberman JN, Coulen C, et al. Value-based insurance design and antidiabetic medication adherence [J]. Am J Pharm Benefits, 2010, 2(1):39-44.
[1] 曹雯佳, 刘学兵, 罗安果, 钟释敏, 邓岚, 王玉琳, 李赵欢. 超声矢量血流成像对2型糖尿病患者颈动脉壁剪切应力的研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 709-717.
[2] 王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[3] 徐志刚, 曹涛, 何亭, 李博奥, 魏婧韬, 张栋梁, 官浩, 杨薛康. 采用抗生素骨水泥治疗糖尿病患者心脏术后胸骨骨髓炎的临床效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 498-502.
[4] 张超, 张珍, 马梁, 穆欢欢, 刘彩玲. 腹腔镜胰十二指肠切除术术后C级胰瘘患者临床特征及影响因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 675-678.
[5] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[6] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[7] 陈宗杰, 胡添松. 肝外伤破裂患者治疗后胆漏发生影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 836-840.
[8] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[9] 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[10] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[11] 周学锋, 董哲毅, 冯哲, 蔡广研, 陈香美. 糖尿病肾脏疾病中西医结合诊疗指南计划书[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 301-305.
[12] 杜军霞, 赵小淋, 王浩然, 高志远, 王曼茜, 万楠熙, 张冬, 丁潇楠, 任琴琴, 段颖洁, 汤力, 朱晗玉. 2 型糖尿病的血液透析患者肠道微生物组学高通量测序分析[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 313-320.
[13] 王贝贝, 崔振义, 王静, 王晗妍, 吕红芝, 李秀婷. 老年股骨粗隆间骨折患者术后贫血预测模型的构建与验证[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 355-362.
[14] 邱岭, 朱旭丽, 浦坚, 邢苗苗, 吴佳玲. 糖尿病肾病患者肠道菌群生态特点与胃肠道功能障碍的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 453-458.
[15] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
阅读次数
全文


摘要